Blog
What Causes Ankles to Swell? A Vascular & Podiatry Expert Explains
Swollen Ankles: Causes, Warning Signs, and When to See a Specialist in Miami Nearly one in three adults will experience noticeable ankle swelling at
Medically Reviewed by
Dr. Yelliann Ruiz Irizary, MD
Board Certified Rheumatologist
Gout has a reputation for being an old-fashioned condition, but in real clinical practice, we still see it often and we see it hurt a lot. When gout hits the big toe, pain can become so intense that even a bedsheet brushing the joint feels unbearable. That pattern is so common that medicine has a specific name for it: podagra.
For many patients, first concern is simple and urgent. Why did this happen to my big toe, and what can we do to stop it from happening again? Those are exactly the right questions. Gout is treatable, but best results come when we move beyond short-term pain relief and treat the underlying uric acid problem that drives repeated flares.
At South Florida Multispecialty Medical Group, our rheumatology team evaluates gout as more than a painful episode. We look at why uric acid is rising, what triggers flares, whether joint damage is already starting and how to build a long-term treatment plan that protects joints, kidneys and quality of life.
Gout is an inflammatory arthritis caused by monosodium urate crystal deposits in and around joints. Those crystals form when uric acid levels in the body stay high enough to allow crystal buildup, then the immune system reacts aggressively and creates sudden pain, swelling, heat and redness.
The big toe is one of the most common places for a gout attack. Mayo Clinic notes that gout most often affects the joint at the base of the big toe, and a systematic review found that acute first metatarsophalangeal joint involvement occurred in about 73 percent of gout cases across studies.
That big toe joint matters more than most people realize. It helps push the body forward during walking, so even a small amount of inflammation can make standing, walking and wearing shoes miserable. Research on first metatarsophalangeal joint gout shows meaningful walking disability, pain-avoidance gait changes and reduced joint function when the condition becomes chronic.
Patients ask this all the time, and honestly, it is one of the most interesting parts of gout. The short answer is that the big toe creates ideal conditions for urate crystal trouble. It is a small joint, it takes repetitive mechanical stress with every step and it sits in a cooler part of the body where crystals can form more easily.
The first metatarsophalangeal joint has a strong and well-documented link to gout. Researchers have proposed that biomechanical loading and repeated physical stress during gait may help explain why this joint is especially vulnerable to crystal deposition and flares.
Several factors likely work together:
Once crystals are present, the next flare can feel as if it came out of nowhere. In reality, the groundwork was already there. The flare is your immune system reacting to those deposited crystals.
Not every painful big toe is gout. Bunions, turf toe, fractures, infections, osteoarthritis and other forefoot disorders can also cause pain. Still, gout often follows a very recognizable pattern.
Common signs of gout in the big toe include:
In many cases, patients describe a dramatic story. They go to bed feeling fine, then wake up with a big toe that looks red, feels hot and hurts so badly they cannot put weight on it. That history does not prove gout by itself, but it makes us take the diagnosis very seriously.
Gout develops when uric acid accumulates faster than the body can clear it. Sometimes the body makes too much uric acid. More often, kidneys do not remove enough of it efficiently.
Several risk factors make gout more likely:
We also remind patients of something important: high uric acid alone does not automatically mean gout, and a “normal” uric acid reading during a flare does not rule gout out. Bloodwork helps guide treatment, but diagnosis should never rely on one lab number in isolation.
When a patient comes in with severe big toe pain, good diagnosis matters. Starting treatment for presumed gout is common, but confirming the condition becomes especially important if attacks are frequent, symptoms are unusual, or another condition such as infection could be in play.
Rheumatologists diagnose gout using a combination of history, physical examination, lab review and sometimes imaging or joint aspiration. According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the gold standard remains identification of urate crystals in joint fluid.
Here is how that process usually works.
We look at how fast pain started, whether the joint turned red and swollen, whether attacks come and go, what foods, alcohol or stressors may have preceded the flare and whether there is a history of kidney stones or prior joint attacks. The classic picture of sudden monoarthritis in the first metatarsophalangeal joint strongly supports gout, but we still keep other causes in mind.
A serum uric acid test can be helpful, especially for long-term planning, but it has limits. Mayo Clinic and the Arthritis Foundation both note that some patients with high uric acid never develop gout, while some patients with gout can have uric acid levels that are not clearly elevated at the time of testing.
We may also order kidney function tests and other labs if medication decisions depend on them. That becomes especially relevant when choosing drugs such as NSAIDs, colchicine or urate-lowering therapy.
When feasible, aspirating fluid from the painful joint and finding monosodium urate crystals under the microscope is the most definitive way to confirm gout. This step is especially useful when symptoms are severe, diagnosis is uncertain or infection must be ruled out.
In first metatarsophalangeal gout, aspiration can be quite informative. Studies in the systematic review found high success rates for acquiring fluid from the big toe joint and high rates of crystal identification when gout is present.
Ultrasound can help identify urate crystal deposits and tophi. Dual-energy CT can also visualize urate crystals, though it is not needed for every patient. X-rays are more useful for assessing chronic damage or excluding other causes than for catching early uncomplicated gout.
When gout attacks the big toe, first goal is fast inflammation control. Patients usually do not care about long-term uric acid strategy in the first hour of severe pain. They want relief, and that is appropriate. Acute flare treatment focuses on calming inflammation quickly and safely.
Main options include NSAIDs, colchicine and corticosteroids. Choice depends on symptom severity, timing, kidney function, stomach ulcer risk, blood thinners, diabetes, cardiovascular history and other medical factors.
Nonsteroidal anti-inflammatory drugs such as ibuprofen, naproxen or prescription alternatives can reduce pain and swelling during a gout flare. They work well for many patients, but they are not right for everyone, particularly people with certain kidney problems, GI bleeding risk or specific cardiovascular concerns.
Colchicine is a classic gout medicine that works best when started early in a flare. It can be very effective, though nausea, diarrhea and other gastrointestinal side effects may limit use in some patients.
Steroids such as prednisone or a joint injection may be used when NSAIDs or colchicine are not ideal, or when inflammation needs fast control. This option can be extremely helpful, though it requires caution in patients with diabetes, uncontrolled blood pressure and other conditions affected by steroid use.
During flares, we also recommend practical measures that patients appreciate because they feel immediately useful: rest the foot, elevate it, avoid pressure on the toe, stay hydrated and do not self-medicate endlessly with over-the-counter drugs without guidance.
This is where many gout cases go off track. A patient has a painful attack, gets medication, starts feeling better, then assumes problem is solved. But a flare is only the visible part of the disease. If uric acid stays high, crystals remain and future attacks become more likely.
Untreated or undertreated gout can progress. Mayo Clinic and the Arthritis Foundation both note that recurrent attacks can involve more joints, last longer and eventually lead to tophi and joint damage.
That is why rheumatologists do more than put out the fire. We work to remove the fuel.
For patients with recurrent gout, tophi, kidney stones, chronic kidney disease, radiographic damage or other signs of ongoing urate burden, long-term urate-lowering therapy becomes a core part of treatment.
The 2020 American College of Rheumatology guidance, as summarized by the American Academy of Family Physicians and the Arthritis Foundation, recommends allopurinol as the preferred first-line urate-lowering therapy for most patients.
Allopurinol reduces uric acid production and is often first choice for long-term control. Rheumatologists typically start low, then adjust the dose over time rather than stopping at a fixed dose too early. That matters because many patients stay undertreated if the dose is never titrated to a therapeutic target.
Febuxostat is another uric acid-lowering option that may be used in selected patients who cannot take allopurinol or do not respond well enough. It is effective, but clinicians weigh cardiovascular considerations when deciding whether it is the right fit.
Some patients benefit from medicines that help the kidneys remove more uric acid, such as probenecid. In severe refractory cases, advanced therapies such as pegloticase may be considered, particularly when tophi are extensive or disease remains uncontrolled despite standard treatment.
Modern gout care is not just “take a pill and hope.” Rheumatologists often use a treat-to-target approach, adjusting therapy to reach and maintain a serum uric acid goal, commonly below 6 mg/dL, and sometimes lower in patients with heavy crystal burden or tophi.
Patients should also know this: starting urate-lowering therapy can temporarily trigger more flares as crystals begin to dissolve and shift. That does not mean treatment failed. It often means treatment is beginning to work, which is why flare prophylaxis with colchicine, NSAIDs or another strategy may be used during the transition period.
Patients often hear, “Just change your diet,” and leave feeling blamed. Diet matters, but gout is not simply a food problem. Genetics, kidney handling of uric acid, medications, weight, metabolic health and other medical conditions all play major roles.
Still, lifestyle changes can absolutely support treatment and reduce flare risk. For a practical starting point, review our printable anti-inflammatory diet guide. Best results usually come when lifestyle steps work together with medical therapy rather than replacing it.
Helpful strategies include:
We tell patients not to obsess over one “miracle” food. Cherries, coffee and vitamin C are often discussed, and some research suggests possible benefit, but these are supporting players, not replacements for a proper gout plan in people with repeated flares.
Ignoring recurrent gout is risky because gout is progressive in many patients. Over time, crystal deposits can accumulate under the skin as tophi, damage cartilage and bone, limit motion and make the joint chronically painful even between obvious flares.
Complications linked to poorly controlled gout include recurrent attacks, permanent joint damage, tophaceous gout and kidney stones. Mayo Clinic also highlights that urate crystals can collect in the urinary tract, contributing to stone formation.
In the big toe specifically, chronic disease can change how a person walks. Research has shown that first metatarsophalangeal joint gout affects pain, disability, range of motion and gait mechanics. Patients who notice changes in their walking pattern may also benefit from a sports podiatrist evaluation alongside rheumatology care.
Some patients with a single mild flare may first speak with a primary care clinician, urgent care doctor or emergency physician. But recurrent or complicated gout deserves rheumatology attention. Rheumatologists specialize in inflammatory arthritis and urate-lowering strategies, which makes a difference when diagnosis is uncertain or flares keep returning. For more context, see our guide on when to see a rheumatologist.
It is time to consider rheumatology care when:
A rheumatologist can also help if gout treatment has been inconsistent for years. That is common. Many patients live through several flares before anyone sets up a real prevention plan.
Big toe pain is not automatically gout. Infection in a joint, traumatic injury, osteoarthritis, bunions and bone spurs and pseudogout can produce overlapping symptoms, which is why proper evaluation matters.
Pseudogout is caused by calcium pyrophosphate crystals, not uric acid crystals. It more often affects joints such as the knee or wrist, while classic gout more commonly targets the big toe, foot, ankle and other lower-extremity joints.
This distinction matters because treatment plans and long-term prevention strategies are different. A person who assumes “all crystal arthritis is the same” can end up on the wrong long-term path.
At SFL Medical Group, gout care starts with listening carefully to the story behind the flare. We evaluate symptom pattern, risk factors, medications, kidney health, metabolic health and whether the big toe pain truly fits gout or points toward another cause.
From there, our rheumatology team builds a treatment plan that addresses both the immediate flare and the long game. That may include flare control, uric acid testing, imaging when needed, prevention planning, diet guidance and follow-up aimed at keeping uric acid at goal and preventing future joint damage.
When big toe gout is treated early and treated completely, outlook is usually very good. Patients often go from recurring painful flares and disrupted mobility to stable control with far fewer attacks and better day-to-day function.
Big toe gout is not just a painful inconvenience. It is often the clearest warning sign that uric acid has been building long before the flare arrived. Once that first attack happens, waiting passively usually gives crystals more time to do damage.
Good gout care combines sharp diagnosis, fast flare control and long-term uric acid management. That is exactly where rheumatologists help most. We do not just treat pain. We work to stop the cycle behind it.
If you are dealing with sudden big toe pain, recurrent gout attacks, joint swelling or concern about uric acid, a rheumatology evaluation can help clarify what is happening and what to do next. Early treatment protects joints, reduces future flares and helps patients get back to walking with much less fear of the next attack.
Dr. Yelliann Ruiz Irizarry is a board-certified rheumatologist and internist, fellowship-trained at the University of Miami/Jackson Health System, with extensive experience in treating complex autoimmune and joint conditions. She serves as Director of Rheumatology and Joints at South Florida Multispecialty Medical Group, specializing in rheumatoid arthritis, lupus, gout, osteoporosis, and joint pain management.
Trust & Transparency: Editorial Policy | Contact Us
More To Explore
Swollen Ankles: Causes, Warning Signs, and When to See a Specialist in Miami Nearly one in three adults will experience noticeable ankle swelling at
Gout has a reputation for being an old-fashioned condition, but in real clinical practice, we still see it often and we see it hurt
©2026 South Florida Multispecialty Medical Group. All Rights Reserved.